FBP primarily decreases the protein level of HMGB1 by promoting its lysosomal degradation upon viral infection. by Penghui Hu (695020)

Adverse events in low-dose naltrexone arm. by Judith I. Tsui (5983160)

Subjects:

CONSORT flow diagram. by Judith I. Tsui (5983160)

Subjects:

Adverse events in placebo arm. by Judith I. Tsui (5983160)

Subjects:

Adverse events in gabapentin arm. by Judith I. Tsui (5983160)

Subjects:

Flubendazole (FBZ) decreases <i>O</i>. <i>ochengi</i> male worm burden and motility in gerbils. by Fidelis Cho-Ngwa (191165)

Features and Consequences of Isopropanol Burning off PTFE–rGO Aerogels by Sergey A. Baskakov (11324315)

Effect of HCQ on proliferative ability after a 7-day stimulation. by Monika M. Kowatsch (11722292)

Subjects:

The decreasing rates of V_p with temperature. by Nazlı Tunar Özcan (14833635)

“…In this study, P-wave velocity (V_p), Brazilian tensile strength (σ_t), uniaxial compression strength (σ_c) of Çankırı rock salt were investigated under different temperatures ranging from 20°C to 250°C since the temperature is a factor that causes changes in some physical and geo-mechanical properties of rocks. …”

Effect of Glycyrrhizae on CYP3A1/2 mRNA expression. by Lulu Ni (12024161)

Subjects:

Supplementary Material for: Allopurinol Use is Associated With Decreased Incidence of Hepatic Decompensation and Overall Mortality Among Individuals With Cirrhosis: a Propensity-ma... by figshare admin karger (2628495)

“…At 18 months, a statistically significantly lower incidence of hepatic decompensation was seen in the overall allopurinol exposure cohort (OR: 0.77; 95% CI: 0.70-0.84), the 100 mg cohort (OR: 0.66; 95% CI: 0.57 to 0.76), and 300 mg cohort (OR: 0.76, 95% CI: 0.62 to 0.94). …”

Mean of the difference between the RV-GLS value of the expert and trainees in four consecutive groups of 25 fetal heart clips. by Chantelle M. de Vet (16535257)

Mean of the difference between the LV-GLS value of the expert and trainees in four consecutive groups of 25 fetal heart clips. by Chantelle M. de Vet (16535257)

Immunoblotting for insulin sensitivity markers. by Dwight D. Harris (14484648)

Subjects:

S3 Data - by Dwight D. Harris (14484648)

Subjects:

S2 Data - by Dwight D. Harris (14484648)

Subjects:

S1 Data - by Dwight D. Harris (14484648)

Subjects:

S4 Data - by Dwight D. Harris (14484648)

Subjects:

Immunoblotting for TGF-beta, alpha-actinin, MMP-13, and mTOR. by Dwight D. Harris (14484648)

Subjects:

Immunoblotting for JAK, STAT, and SMAD. by Dwight D. Harris (14484648)

Subjects: